Holly Villamagna, M.D.

  • Assistant Professor of Medicine, Division of Infectious Diseases, School of Medicine
  • Medical Director, Infection Prevention & Control, Hillsboro Medical Center
  • Medical Director, Occupational Health, Hillsboro Medical Center

Biography

After earning a degree in print journalism at USC, Dr. Villamagna completed medical school and internal medicine residency in her home state of Nevada, followed by ID fellowship at OHSU. She then completed the Leadership in Epidemiology, Antimicrobial Stewardship, and Public Health (LEAP) Fellowship, during which she worked with Oregon Health Authority to study risk factors for large COVID outbreaks in long-term care facilities.

Dr. Villamagna’s clinical interests include inpatient and outpatient general infectious diseases. Since late 2021, she has been the medical director for both Infection Prevention and Employee Health at Hillsboro Medical Center and has greatly enjoyed helping to build both programs. She is also interested in medical education and is the clinical director for two medical student intersessions, "Infection" and "COVID and Pandemics." Her favorite role of all is as mom to her two young children. Outside of all that, she enjoys running marathons, talking about running marathons, and attempting to grow vegetables in the backyard. 

Education and training

  • Degrees

    • B.A., 2011, University of Southern California
    • M.D., 2015, University of Nevada, Reno School of Medicine
  • Residency

    • Internal Medicine, University of Nevada, Las Vegas 2018
  • Fellowship

    • Infectious Diseases, Oregon Health & Science University, 2020
    • Leadership in Epidemiology, Antimicrobial Stewardship, and Public Health (LEAP) Fellowship, 2021
  • Certifications

    • American Board of Internal Medicine, 2018
    • American Board of Internal Medicine, Infectious Diseases, 2020

Publications

Selected publications

  • Villamagna AH, Bonura EM.  Infectious diseases simulation for medical students: experiential instruction on personal protective equipment.  MedEdPORTAL. 2020;16:11031.  https://doi.org/10.15766/mep_2374-8265.11031
  • Fontana LM, Villamagna AH, Sikka MK, McGregor JC. Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature. Infect Control Hosp Epidemiol. 2021 Jun;42(6):659-668. https://doi.org/10.1017/ice.2020.1273
  • Villamagna AH, Gore SJ, Lewis JS, Doggett JS. The Need for Antiviral Drugs for Pandemic Coronaviruses From a Global Health Perspective. Front Med (Lausanne). 2020 Dec 22;7:596587. https://doi.org/10.3389/fmed.2020.596587
  • Villamagna, AH and Bonura, EM. "COVID-19 Curriculum Highlighting the Importance of Trauma-Informed Pedagogy.” Med Educ. 2024 May;58(5):619-620.
  • Pierce C, Villamagna AH, Cieslak P, Liko J. Notes from the Field: Tetanus in an Unvaccinated Man from Mexico – Oregon, 2022.  MMWR Morb Mortal Wkly Rep 2023;72:665–666.
  • Villamagna AH, Beste LA, Borgerding J, Lowy E, Hauser RG, Ross DM, Maier MM. Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration. Journal of Addiction Medicine. 2023 Jan 12; 10.1097/ADM.0000000000001134